Hoth Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
327
across all filing types
Latest filing
2026-06-02
Regulatory Filings
Country
US
United States of America
Listing
US
HOTH
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company that acts as a catalyst in early-stage pharmaceutical research and development. The company focuses on advancing promising drug candidates from discovery through pre-clinical and clinical testing to address unmet medical needs. Its development pipeline includes innovative therapeutics for conditions such as skin disorders. Guided by a patient-centric mission to improve quality of life, Hoth Therapeutics also utilizes artificial intelligence to support its drug development programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-02 | English | |
| CURRENT REPORT | 2026-05-28 | English | |
| PROSPECTUS SUPPLEMENT | 2026-05-27 | English | |
| CURRENT REPORT | 2026-05-27 | English | |
| CURRENT REPORT | 2026-05-21 | English | |
| QUARTERLY REPORT | 2026-05-15 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47938917 | CURRENT REPORT | 2026-06-02 | English | ||
| 47860174 | CURRENT REPORT | 2026-05-28 | English | ||
| 47846174 | PROSPECTUS SUPPLEMENT | 2026-05-27 | English | ||
| 47540654 | CURRENT REPORT | 2026-05-27 | English | ||
| 46753358 | CURRENT REPORT | 2026-05-21 | English | ||
| 46362293 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 41998159 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-06 | English | ||
| 41071328 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-04 | English | ||
| 34650412 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-16 | English | ||
| 34650389 | 424B5 - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-16 | English | ||
| 33192520 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-02 | English | ||
| 33180659 | 424B5 - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-02 | English | ||
| 33066014 | 10-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-03-27 | English | ||
| 13051071 | CURRENT REPORT | 2026-01-16 | English | ||
|
2025
1 filing
| |||||
| 13051074 | Regulatory Filings 2025 | 2025-12-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Predict S.p.A.
Develops and distributes AI medical solutions for imaging, …
|
PRE | IT | Professional, scientific and te… |
|
PRESCIENT THERAPEUTICS LIMITED
Clinical-stage oncology firm developing modular cell therap…
|
PTX | AU | Professional, scientific and te… |
|
PreveCeutical Medical
Health sciences company researching and developing innovati…
|
PREV | CA | Professional, scientific and te… |
|
ProMIS Neurosciences Inc.
Develops selective antibody therapeutics for neurodegenerat…
|
PMN | CA | Professional, scientific and te… |
|
Propanc Biopharma, Inc.
Clinical-stage company developing cancer treatments to prev…
|
PPCB | US | Professional, scientific and te… |
|
ProQR Therapeutics N.V.
Develops RNA therapies for severe genetic disorders using i…
|
PRQR | NL | Professional, scientific and te… |
|
Prostatype Genomics AB
Develops a genetic test that assesses prostate cancer aggre…
|
PROGEN | SE | Professional, scientific and te… |
|
Protagenic Therapeutics, Inc.\new
Develops peptide-based therapeutics for stress-related neur…
|
PTIX | US | Professional, scientific and te… |
|
Protara Therapeutics, Inc.
Clinical-stage biopharma developing therapies for cancer an…
|
TARA | US | Professional, scientific and te… |
|
PROTEINA CO.,LTD.
A biotech firm analyzing protein interactions for drug and …
|
468530 | KR | Professional, scientific and te… |
Hoth Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34935/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34935 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34935 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34935 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34935}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Hoth Therapeutics, Inc. (id: 34935)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.